Myxedematous psychosis

Jump to: navigation, search
Myxedematous psychosis

WikiDoc Resources for Myxedematous psychosis

Articles

Most recent articles on Myxedematous psychosis

Most cited articles on Myxedematous psychosis

Review articles on Myxedematous psychosis

Articles on Myxedematous psychosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Myxedematous psychosis

Images of Myxedematous psychosis

Photos of Myxedematous psychosis

Podcasts & MP3s on Myxedematous psychosis

Videos on Myxedematous psychosis

Evidence Based Medicine

Cochrane Collaboration on Myxedematous psychosis

Bandolier on Myxedematous psychosis

TRIP on Myxedematous psychosis

Clinical Trials

Ongoing Trials on Myxedematous psychosis at Clinical Trials.gov

Trial results on Myxedematous psychosis

Clinical Trials on Myxedematous psychosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Myxedematous psychosis

NICE Guidance on Myxedematous psychosis

NHS PRODIGY Guidance

FDA on Myxedematous psychosis

CDC on Myxedematous psychosis

Books

Books on Myxedematous psychosis

News

Myxedematous psychosis in the news

Be alerted to news on Myxedematous psychosis

News trends on Myxedematous psychosis

Commentary

Blogs on Myxedematous psychosis

Definitions

Definitions of Myxedematous psychosis

Patient Resources / Community

Patient resources on Myxedematous psychosis

Discussion groups on Myxedematous psychosis

Patient Handouts on Myxedematous psychosis

Directions to Hospitals Treating Myxedematous psychosis

Risk calculators and risk factors for Myxedematous psychosis

Healthcare Provider Resources

Symptoms of Myxedematous psychosis

Causes & Risk Factors for Myxedematous psychosis

Diagnostic studies for Myxedematous psychosis

Treatment of Myxedematous psychosis

Continuing Medical Education (CME)

CME Programs on Myxedematous psychosis

International

Myxedematous psychosis en Espanol

Myxedematous psychosis en Francais

Business

Myxedematous psychosis in the Marketplace

Patents on Myxedematous psychosis

Experimental / Informatics

List of terms related to Myxedematous psychosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Myxedema psychosis, more colloquially known as myxedema madness, is a relatively uncommon consequence of hypothyroidism, particularly Hashimoto's thyroiditis. A chronically under-active thyroid can lead to slowly progressive dementia, delirium, and in extreme cases to hallucinations, coma, or psychosis, particularly in the elderly.

Treatment is via the standard treatment for hypothyroidism with thyroxine replacement.

Oral T4, or in especially acute cases liothyronine, a sodium salt of T3. Hormone replacement in these patients usually reverses the psychotic symptoms, but may not help with cognitive deficits caused by changes in metabolic activity in the CNS.

The "myxedema" part of the name simply refers to the pitting edema common to hypothyroidism.

References

Hypothyroidism Presenting as Psychosis: Myxedema Madness Revisited. Heinrich TW, Grahm G. Prim Care Companion J Clin Psychiatry. 2003; 5(6): 260-266. [3]

Cost Effectiveness of Myxedematous psychosis

| group5 = Clinical Trials Involving Myxedematous psychosis | list5 = Ongoing Trials on Myxedematous psychosis at Clinical Trials.govTrial results on Myxedematous psychosisClinical Trials on Myxedematous psychosis at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Myxedematous psychosis | list6 = US National Guidelines Clearinghouse on Myxedematous psychosisNICE Guidance on Myxedematous psychosisNHS PRODIGY GuidanceFDA on Myxedematous psychosisCDC on Myxedematous psychosis


| group7 = Textbook Information on Myxedematous psychosis | list7 = Books and Textbook Information on Myxedematous psychosis


| group8 = Pharmacology Resources on Myxedematous psychosis | list8 = AND (Dose)}} Dosing of Myxedematous psychosisAND (drug interactions)}} Drug interactions with Myxedematous psychosisAND (side effects)}} Side effects of Myxedematous psychosisAND (Allergy)}} Allergic reactions to Myxedematous psychosisAND (overdose)}} Overdose information on Myxedematous psychosisAND (carcinogenicity)}} Carcinogenicity information on Myxedematous psychosisAND (pregnancy)}} Myxedematous psychosis in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Myxedematous psychosis


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Myxedematous psychosis | list9 = AND (pharmacogenomics)}} Genetics of Myxedematous psychosisAND (pharmacogenomics)}} Pharmacogenomics of Myxedematous psychosisAND (proteomics)}} Proteomics of Myxedematous psychosis


| group10 = Newstories on Myxedematous psychosis | list10 = Myxedematous psychosis in the newsBe alerted to news on Myxedematous psychosisNews trends on Myxedematous psychosis


| group11 = Commentary on Myxedematous psychosis | list11 = Blogs on Myxedematous psychosis

| group12 = Patient Resources on Myxedematous psychosis | list12 = Patient resources on Myxedematous psychosisDiscussion groups on Myxedematous psychosisPatient Handouts on Myxedematous psychosisDirections to Hospitals Treating Myxedematous psychosisRisk calculators and risk factors for Myxedematous psychosis


| group13 = Healthcare Provider Resources on Myxedematous psychosis | list13 = Symptoms of Myxedematous psychosisCauses & Risk Factors for Myxedematous psychosisDiagnostic studies for Myxedematous psychosisTreatment of Myxedematous psychosis

| group14 = Continuing Medical Education (CME) Programs on Myxedematous psychosis | list14 = CME Programs on Myxedematous psychosis

| group15 = International Resources on Myxedematous psychosis | list15 = Myxedematous psychosis en EspanolMyxedematous psychosis en Francais

| group16 = Business Resources on Myxedematous psychosis | list16 = Myxedematous psychosis in the MarketplacePatents on Myxedematous psychosis

| group17 = Informatics Resources on Myxedematous psychosis | list17 = List of terms related to Myxedematous psychosis


}}



Linked-in.jpg